Expertise in
7
conditions

Gian M. De Marchis

Cantonal Hospital St. Gallen, 
Sankt Gallen, SG, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Cantonal Hospital St. Gallen, 
Sankt Gallen, SG, CH 
OverviewLocationsClinical Research

Overview

Gian De Marchis practices in Sankt Gallen, Switzerland. Mr. De Marchis is highly rated in 7 conditions, according to our data. His top areas of expertise are Stroke, Status Epilepticus, Atrial Fibrillation, Thrombectomy, and Gastrostomy.

His clinical research consists of co-authoring 178 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Cantonal Hospital St. Gallen, Sankt Gallen, SG, Switzerland
Other Locations
Basel, BS, Switzerland
Kantonsspital St Gallen, St Gallen, Switzerland
Kantonsspital Aarau
Aarau, AG, Switzerland
Bern, BE, Switzerland
Sulz / Felix, ZH, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Recruiting
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drugs: Dabigatran, Apixaban, Edoxaban, Aspirin, Clopidogrel
Study Phase: Phase 3
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Not Applicable
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Enrollment Status: Unknown
Publish Date: November 11, 2021
View 2 Less Clinical Trial

178 Total Publications

Tenecteplase or alteplase for acute ischemic stroke beyond 4.5 hours of last known well. A pooled analysis of the TETRIS and EVATRISP registries.
Tenecteplase or alteplase for acute ischemic stroke beyond 4.5 hours of last known well. A pooled analysis of the TETRIS and EVATRISP registries.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Marchis's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile